National Institutes of Health

Description

Develop the basic and preclinical framework needed for development of second and subsequent generations of PrEP agents Create a rational pipeline for the discovery of New Molecular Entities (NMEs) and the identification of existing antiretrovirals (including those that are approved for HIV treatment, and those that are not approved but may have clinical data) that can be used for the next generation of PrEP agents Develop preclinical algorithms with clear go/no go criteria for identifying and prioritizing PrEP candidates for advancement to clinical evaluation Generate PK/PD models to assess protective effects at mucosal sites of HIV transmission Conduct proof-of-concept safety and efficacy studies in animal models

Who can apply

• State governments
• County governments
• City or township governments
• Special district governments
• Independent school districts
• Public and State controlled institutions of higher education
• Native American tribal governments (Federally recognized)
• Public housing authorities / Indian housing authorities
• Native American tribal organizations (other than Federally recognized)
• Nonprofits with 501(c)(3) status (other than higher education)
• Nonprofits without 501(c)(3) status (other than higher education)
• Private institutions of higher education
• For-profit organizations other than small businesses
• Small businesses
• Others

Contact

NIH OER Webmaster<br/>FBOWebmaster@OD.NIH.GOV<br/>
FBOWebmaster@OD.NIH.GOV